Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Lymph nodes and survival in pancreatic neuroendocrine tumors.

Krampitz GW, Norton JA, Poultsides GA, Visser BC, Sun L, Jensen RT.

Arch Surg. 2012 Sep;147(9):820-7. doi: 10.1001/archsurg.2012.1261.

2.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
3.

Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, Hawkins WG.

Ann Surg. 2014 Feb;259(2):197-203. doi: 10.1097/SLA.0000000000000348.

4.

Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.

Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA.

Ann Surg Oncol. 2014 Oct;21(11):3515-21. doi: 10.1245/s10434-014-3769-4. Epub 2014 May 20.

5.

Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?

Sallinen V, Haglund C, Seppänen H.

Surgery. 2015 Dec;158(6):1556-63. doi: 10.1016/j.surg.2015.04.035. Epub 2015 Jun 10.

PMID:
26070847
6.

Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.

Curran T, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N.

J Gastrointest Surg. 2015 Jan;19(1):152-60; discussion 160. doi: 10.1007/s11605-014-2624-z. Epub 2014 Aug 14.

PMID:
25118642
7.

Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.

Boninsegna L, Panzuto F, Partelli S, Capelli P, Delle Fave G, Bettini R, Pederzoli P, Scarpa A, Falconi M.

Eur J Cancer. 2012 Jul;48(11):1608-15. doi: 10.1016/j.ejca.2011.10.030. Epub 2011 Nov 28.

PMID:
22129889
8.

Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.

Benassai G, Mastrorilli M, Mosella F, Mosella G.

J Exp Clin Cancer Res. 1999 Mar;18(1):23-8.

PMID:
10374672
9.

Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.

Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK.

Pancreas. 2012 Aug;41(6):840-4. doi: 10.1097/MPA.0b013e31823cdaa0.

PMID:
22781907
10.

Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.

Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M.

J Gastroenterol. 2012 Jun;47(6):678-85. doi: 10.1007/s00535-012-0540-0. Epub 2012 Feb 17.

PMID:
22350698
11.

Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.

Postlewait LM, Ethun CG, Baptiste GG, Le N, McInnis MR, Cardona K, Russell MC, Sarmiento JM, Kooby DA, Staley CA, Maithel SK.

J Surg Oncol. 2016 Sep;114(4):440-5. doi: 10.1002/jso.24338. Epub 2016 Jun 22.

PMID:
27334541
12.
13.

Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size.

Kishi Y, Shimada K, Nara S, Esaki M, Hiraoka N, Kosuge T.

Ann Surg Oncol. 2014 Sep;21(9):2882-8. doi: 10.1245/s10434-014-3701-y. Epub 2014 Apr 18.

PMID:
24740828
14.

[Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].

Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):195-200. German.

PMID:
17252361
15.

Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.

Birnbaum DJ, Turrini O, Vigano L, Russolillo N, Autret A, Moutardier V, Capussotti L, Le Treut YP, Delpero JR, Hardwigsen J.

Ann Surg Oncol. 2015 Mar;22(3):1000-7. doi: 10.1245/s10434-014-4016-8. Epub 2014 Sep 5.

PMID:
25190116
16.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
17.

A personal experience with pancreatic and duodenal neuroendocrine tumors.

Jordan PH Jr.

J Am Coll Surg. 1999 Nov;189(5):470-82.

PMID:
10549736
18.

Lymph node evaluation for treatment of adenocarcinoma of the pancreas.

Marmor S, Burke EE, Portschy PR, Virnig BA, Jensen EH, Tuttle TM.

Surg Oncol. 2015 Sep;24(3):284-91. doi: 10.1016/j.suronc.2015.06.006. Epub 2015 Aug 7.

PMID:
26303825
19.

Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.

Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK.

Am J Surg Pathol. 2011 Feb;35(2):228-34. doi: 10.1097/PAS.0b013e318206c37a.

PMID:
21263243
20.

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.

Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH.

Am J Surg. 1996 Nov;172(5):463-8; discussion 468-9.

PMID:
8942545

Supplemental Content

Support Center